ALTEOGEN

196170 · KRX · KRW

₩259,500.00Change from previous close: −2.08%Absolute change: −₩5,500.00

Close · October 2, 2026

At a glance

Revenue growth
+109.87%
2025 vs 2024
Net income growth
+127.57%
2025 vs 2024
Net margin
65.6%
2024: 60.5%

Financial data

Amounts in millions of KRW; per-share values in KRW; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue215,859102,85596,52328,806—
Cost of revenue50,23438,78665,32424,275—
Gross profit165,62564,06931,1994,531—
Selling, general and administrative5,5503,8005,0215,411—
Research and development37,04824,55025,30618,660—
Operating income106,90025,404-9,737-29,374—
EBIT173,70337,287-2,893-9,544—
EBITDA179,19340,137440-6,890—
Interest expense10,967675671425—
Pre-tax income162,73636,612-3,564-9,970—
Income tax17,563-24,07817.8108—
Net income141,66662,252-3,372-8,146—
Net income to common shareholders141,66662,252-3,372-8,146—
Basic EPS2,040.77901.54-50.00-122.31—
Diluted EPS1,993.08894.62-50.00-122.31—
Average shares (basic)69.469.167.466.6—
Average shares (diluted)71.169.667.468.8—